{
  "DOI": "10.1007/s10689-023-00327-2",
  "ISSN": [
    "1389-9600",
    "1573-7292"
  ],
  "URL": "http://dx.doi.org/10.1007/s10689-023-00327-2",
  "abstract": "\u003cjats:title\u003eAbstract\u003c/jats:title\u003e\u003cjats:p\u003e\u003cjats:italic\u003eCHEK2\u003c/jats:italic\u003e is a well-established breast cancer susceptibility gene. The most frequent pathogenic \u003cjats:italic\u003eCHEK2\u003c/jats:italic\u003e variant is 1100delC, a loss-of-function mutation conferring 2-fold risk for breast cancer. This gene also harbors other rare variants encountered in the clinical gene panels for hereditary cancer. One of these is \u003cjats:italic\u003eCHEK2\u003c/jats:italic\u003e c.1312 G \u0026gt; T, p.(Asp438Tyr) in the kinase domain of the protein, but due to its rarity its clinical significance for breast cancer predisposition has remained unclear. Here, we tested the prevalence of \u003cjats:italic\u003eCHEK2\u003c/jats:italic\u003e p.(Asp438Tyr) allele showing enrichment in the Northern Finnish population, in a total of 2284 breast cancer patients from this geographical region. Genotyping was performed for DNA samples extracted from peripheral blood using high-resolution melt analysis. Fourteen \u003cjats:italic\u003eCHEK2\u003c/jats:italic\u003e p.(Asp438Tyr) carriers were identified (14/2284, 0.6%, P = 0.67): two in the cohort of breast cancer cases with the indication of inherited disease susceptibility (2/281, 0.7%, P = 1.00) and twelve in the breast cancer cohort unselected for the family history of disease and age at disease onset (12/2003, 0.6%, P = 0.66). This frequency did not differ from the frequency in the general population (10/1299, 0.8%). No \u003cjats:italic\u003eCHEK2\u003c/jats:italic\u003e p.(Asp438Tyr) homozygotes were identified. Our results indicate that \u003cjats:italic\u003eCHEK2\u003c/jats:italic\u003e p.(Asp438Tyr) carriers do not have an increased risk for breast cancer and the classification of the \u003cjats:italic\u003eCHEK2\u003c/jats:italic\u003e p.(Asp438Tyr) variant can be changed from the variant of uncertain significance (VUS) to likely benign for breast cancer.\u003c/jats:p\u003e",
  "alternative-id": [
    "327"
  ],
  "assertion": [
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Received",
      "name": "received",
      "order": 1,
      "value": "22 November 2022"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "Accepted",
      "name": "accepted",
      "order": 2,
      "value": "15 January 2023"
    },
    {
      "group": {
        "label": "Article History",
        "name": "ArticleHistory"
      },
      "label": "First Online",
      "name": "first_online",
      "order": 3,
      "value": "19 January 2023"
    },
    {
      "group": {
        "label": "Declarations",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 1
    },
    {
      "group": {
        "label": "Conflict of interest",
        "name": "EthicsHeading"
      },
      "name": "Ethics",
      "order": 2,
      "value": "The authors declare that there is no conflict of interest."
    }
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Kumpula",
      "given": "Timo A.",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Koivuluoma",
      "given": "Susanna",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Soikkonen",
      "given": "Leila",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Vorimo",
      "given": "Sandra",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Moilanen",
      "given": "Jukka",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Winqvist",
      "given": "Robert",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Mantere",
      "given": "Tuomo",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Kuismin",
      "given": "Outi",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Pylkäs",
      "given": "Katri",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "Familial Cancer"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": [
      "link.springer.com"
    ]
  },
  "created": {
    "date-parts": [
      [
        2023,
        1,
        19
      ]
    ],
    "date-time": "2023-01-19T01:41:20Z",
    "timestamp": 1674092480000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        6,
        16
      ]
    ],
    "date-time": "2023-06-16T04:26:07Z",
    "timestamp": 1686889567000
  },
  "funder": [
    {
      "name": "Sigrid Jusélius foundation"
    },
    {
      "DOI": "10.13039/501100002341",
      "award": [
        "307808"
      ],
      "doi-asserted-by": "publisher",
      "name": "Academy of Finland"
    },
    {
      "name": "the Cancer Foundation of Finland sr"
    },
    {
      "name": "University of Oulu including Oulu University Hospital"
    }
  ],
  "indexed": {
    "date-parts": [
      [
        2023,
        6,
        16
      ]
    ],
    "date-time": "2023-06-16T04:40:52Z",
    "timestamp": 1686890452921
  },
  "is-referenced-by-count": 0,
  "issn-type": [
    {
      "type": "print",
      "value": "1389-9600"
    },
    {
      "type": "electronic",
      "value": "1573-7292"
    }
  ],
  "issue": "3",
  "issued": {
    "date-parts": [
      [
        2023,
        1,
        19
      ]
    ]
  },
  "journal-issue": {
    "issue": "3",
    "published-print": {
      "date-parts": [
        [
          2023,
          7
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            1,
            19
          ]
        ],
        "date-time": "2023-01-19T00:00:00Z",
        "timestamp": 1674086400000
      }
    },
    {
      "URL": "https://creativecommons.org/licenses/by/4.0",
      "content-version": "vor",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2023,
            1,
            19
          ]
        ],
        "date-time": "2023-01-19T00:00:00Z",
        "timestamp": 1674086400000
      }
    }
  ],
  "link": [
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-023-00327-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/article/10.1007/s10689-023-00327-2/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://link.springer.com/content/pdf/10.1007/s10689-023-00327-2.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "291-294",
  "prefix": "10.1007",
  "published": {
    "date-parts": [
      [
        2023,
        1,
        19
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2023,
        1,
        19
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2023,
        7
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1016/j.dnarep.2004.03.033",
      "author": "J Ahn",
      "doi-asserted-by": "publisher",
      "first-page": "1039",
      "journal-title": "DNA Repair (Amst)",
      "key": "327_CR1",
      "unstructured": "Ahn J, Urist M, Prives C (2004) The Chk2 protein kinase. DNA Repair (Amst) 3:1039–1047",
      "volume": "3",
      "year": "2004"
    },
    {
      "DOI": "10.1038/35103059",
      "author": "J Bartek",
      "doi-asserted-by": "publisher",
      "first-page": "877",
      "journal-title": "Nat Rev Mol Cell Biol",
      "key": "327_CR2",
      "unstructured": "Bartek J, Falck J, Lukas J (2001) Chk2 kinase - A busy messenger. Nat Rev Mol Cell Biol 2:877–886. https://doi.org/10.1038/35103059",
      "volume": "2",
      "year": "2001"
    },
    {
      "DOI": "10.1038/ng879",
      "author": "H Meijers-Heijboer",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "Nat Genet",
      "key": "327_CR3",
      "unstructured": "Meijers-Heijboer H, van den Ouweland A, Klijn J et al (2002) Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations: the CHEK2-breast cancer consortium. Nat Genet 31:55–59. https://doi.org/10.1038/ng879",
      "volume": "31",
      "year": "2002"
    },
    {
      "DOI": "10.1086/341943",
      "doi-asserted-by": "publisher",
      "key": "327_CR4",
      "unstructured": "Vahteristo P, Bartkova J, Eerola H et al (2002) A CHEK2 genetic variant contributing. to a Substantial Fraction of Familial Breast Cancer. Am J Hum Genet 71:432-438. https://doi.org/10.1086/341943"
    },
    {
      "DOI": "10.1186/bcr2810",
      "doi-asserted-by": "publisher",
      "key": "327_CR5",
      "unstructured": "le Calvez-Kelm F, Lesueur F, Damiola F et al (2011) Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study. Breast Cancer Res 13. https://doi.org/10.1186/bcr2810"
    },
    {
      "DOI": "10.1002/ijc.23026",
      "author": "DW Bell",
      "doi-asserted-by": "publisher",
      "first-page": "2661",
      "journal-title": "Int J Cancer",
      "key": "327_CR6",
      "unstructured": "Bell DW, Kim SH, Godwin AK et al (2007) Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts. Int J Cancer 121:2661–2667. https://doi.org/10.1002/ijc.23026",
      "volume": "121",
      "year": "2007"
    },
    {
      "DOI": "10.1002/humu.23728",
      "author": "A Delimitsou",
      "doi-asserted-by": "publisher",
      "first-page": "631",
      "journal-title": "Hum Mutat",
      "key": "327_CR7",
      "unstructured": "Delimitsou A, Fostira F, Kalfakakou D et al (2019) Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system. Hum Mutat 40:631–648. https://doi.org/10.1002/humu.23728",
      "volume": "40",
      "year": "2019"
    },
    {
      "DOI": "10.1002/ijc.32385",
      "author": "P Kleiblova",
      "doi-asserted-by": "publisher",
      "first-page": "1782",
      "journal-title": "Int J Cancer",
      "key": "327_CR8",
      "unstructured": "Kleiblova P, Stolarova L, Krizova K et al (2019) Identification of deleterious germline CHEK2 mutations and their association with breast and ovarian cancer. Int J Cancer 145:1782–1797. https://doi.org/10.1002/ijc.32385",
      "volume": "145",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41586-020-2308-7",
      "author": "KJ Karczewski",
      "doi-asserted-by": "publisher",
      "first-page": "434",
      "journal-title": "Nature",
      "key": "327_CR9",
      "unstructured": "Karczewski KJ, Francioli LC, Tiao G et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581:434–443. https://doi.org/10.1038/s41586-020-2308-7",
      "volume": "581",
      "year": "2020"
    },
    {
      "DOI": "10.1086/301880",
      "author": "P Huusko",
      "doi-asserted-by": "publisher",
      "first-page": "1544",
      "journal-title": "Am J Hum Genet",
      "key": "327_CR10",
      "unstructured": "Huusko P, Pääkkönen K, Launonen V et al (1998) Evidence of founder mutations in finnish BRCA1 and BRCA2 families. Am J Hum Genet 62:1544–1548",
      "volume": "62",
      "year": "1998"
    },
    {
      "DOI": "10.1038/nature05609",
      "author": "H Erkko",
      "doi-asserted-by": "publisher",
      "first-page": "316",
      "journal-title": "Nature",
      "key": "327_CR11",
      "unstructured": "Erkko H, Xia B, Nikkilä J et al (2007) A recurrent mutation in PALB2 in finnish cancer families. Nature 446:316–319. https://doi.org/10.1038/nature05609",
      "volume": "446",
      "year": "2007"
    },
    {
      "DOI": "10.1371/journal.pgen.1005816",
      "doi-asserted-by": "publisher",
      "key": "327_CR12",
      "unstructured": "Mantere T, Winqvist R, Kauppila S et al (2016) Targeted next-generation sequencing identifies a recurrent mutation in MCPH1 associating with Hereditary breast Cancer susceptibility. PLoS Genet 12. https://doi.org/10.1371/journal.pgen.1005816"
    },
    {
      "DOI": "10.1007/s10549-010-1050-5",
      "author": "J Brunet",
      "doi-asserted-by": "publisher",
      "first-page": "7",
      "journal-title": "Breast Cancer Res Treat",
      "key": "327_CR13",
      "unstructured": "Brunet J (2010) Hereditary breast cancer and genetic counseling in young women. Breast Cancer Res Treat 123:7–9. https://doi.org/10.1007/s10549-010-1050-5",
      "volume": "123",
      "year": "2010"
    },
    {
      "DOI": "10.1016/j.ejca.2020.10.033",
      "doi-asserted-by": "publisher",
      "key": "327_CR14",
      "unstructured": "Koivuluoma S, Tervasmäki A, Kauppila S et al (2021) Exome sequencing identifies a recurrent variant in SERPINA3 associating with hereditary susceptibility to breast cancer. Eur J Cancer 143. https://doi.org/10.1016/j.ejca.2020.10.033"
    },
    {
      "DOI": "10.1186/s13073-022-01052-8",
      "doi-asserted-by": "publisher",
      "key": "327_CR15",
      "unstructured": "Dorling L, Carvalho S, Allen J et al (2022) Breast cancer risks associated with missense variants in breast cancer susceptibility genes. Genome Med 14. https://doi.org/10.1186/s13073-022-01052-8"
    },
    {
      "DOI": "10.1158/0008-5472.CAN-21-1845",
      "author": "RACM Boonen",
      "doi-asserted-by": "publisher",
      "first-page": "615",
      "journal-title": "Cancer Res",
      "key": "327_CR16",
      "unstructured": "Boonen RACM, Wiegant WW, Celosse N et al (2022) Functional analysis identifies damaging CHEK2 missense Variants Associated with increased Cancer risk. Cancer Res 82:615–631. https://doi.org/10.1158/0008-5472.CAN-21-1845",
      "volume": "82",
      "year": "2022"
    }
  ],
  "reference-count": 16,
  "references-count": 16,
  "resource": {
    "primary": {
      "URL": "https://link.springer.com/10.1007/s10689-023-00327-2"
    }
  },
  "score": 0,
  "short-container-title": [
    "Familial Cancer"
  ],
  "source": "Crossref",
  "title": [
    "Evaluating the role of CHEK2 p.(Asp438Tyr) allele in inherited breast cancer predisposition"
  ],
  "type": "journal-article",
  "update-policy": "http://dx.doi.org/10.1007/springer_crossmark_policy",
  "volume": "22"
}